AXL, a member of the TAM family tyrosine kinase receptors, is frequently overexpressed in various solid tumors, including RCC (116), where it interacts with its high-affinity ligand growth arrest-specific protein 6 to promote proliferation, survival, angiogenesis, and invasion (117). Here, AXL is linked to renal cell carcinoma.